Novartis is a company in which country and Novartis Pharmaceuticals is a company in which country

Novartis. The big N division is also famous for its many products, after all, they are all rich owners, and there are many follow-up new products. Novartis' best-selling product in the world is Fingomore.

Brother Joe also reserved a place for secukinumab, this drug has been long-awaited in China, after all, it has a reputation abroad, and it has grown rapidly after entering China. In the case of Novartis' cardiovascular products, Daiwen and Bebot have all hit the streets.

01 Noxinto.

Nuoxintuo is a star product of heart failure, this year into the medical insurance, began to expand a large number of recruitment, many Puqiang resignation partners have gone to Nuoxinto, I feel that Novartis is next year to make a big effort. But the growth of the Noxinto index is not ambiguous, almost 6 times, of course, it is still incomparable with Division A!

02 Turinga (Fingolimod).

Zeringa (fingolimod) is used for multiple sclerosis type (RMS) in patients 10 years of age or older, and it is currently the only multiple sclerosis disease modification (DMT) drug with a pediatric indication. In 2018, the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) was selected into the first batch of "List of Overseas New Drugs Urgently Needed for Clinical Use".

It can be said that this product is very good, and it is currently the only multiple sclerosis disease modification (DMT) drug with a pediatric indication, but it doesn't seem to be very cheap. However, this rare disease position has strong product strength, few customers, and professional depth, which can make the representative get a great sense of career achievement and self-worth, so Brother Joe thinks that this product post is a good post.

03 ranibizumab.

Rabizumab is an important product of Novartis in the field of ophthalmology, which was launched in 2006, but later Bayer's aflibercept was launched, and then it surpassed ranibizumab, and then Kanghong's conbercept was also launched. In 2017, ranibizumab and conbercept were both included in the medical insurance and maintained their competitiveness, but this year aflibercept was also listed, and the three products were almost the same, and it was another bloody storm!

But this product is fortunate to be a product in a small field, and there are ophthalmic equipment giants such as Alcon and Zeiss in this field.

04 secukinumab.

When secukinumab has not yet entered China, domestic experts have been looking forward to it, and patients are also looking forward to it, after all, in the field of psoriasis, this product is an epoch-making product. After the listing, due to the clinical recognition, the market was quickly opened, and the bonus policy of sales is also very good, and the sales are also willing to run the market, and now it seems that the development is good.

But Eli Lilly's competing products are also on the market, and the same target depends on the combat effectiveness of the two marketing strategies and sales teams, but in terms of influence alone, Su Jin is still slightly better.

Novartis is a Swiss pharmaceutical company and a well-known pharmaceutical company in the world.

Novartis. Novartis, a multinational conglomerate in the global pharmaceutical and healthcare industry, is headquartered in Basel, Switzerland.

Novartis. Pharma is a Swiss company. Novartis, a multinational enterprise in the global pharmaceutical and health industry, is one of the world's three largest pharmaceutical companies, and is headquartered in Basel, Switzerland.

The business covers more than 150 countries and regions around the world. Novartis China Headquarters was established in 1997.

Novartis has a diverse portfolio of world-leading businesses in the areas of innovative patented medicines, eye care, generics, consumer health, and vaccines and diagnostics. Novartis' name, Novartis, is derived from Latin.

novaeartes, which means "new technology". The company's Chinese name, Novartis, means commitment to China, that is, commitment to improve the health level and quality of life of the Chinese people through continuous innovation of products and services.

Summary. It is headquartered in Basel, Switzerland.

It is headquartered in Basel, Switzerland.

That is, Novartis Group, a multinational enterprise in the global pharmaceutical and health industry, and one of the world's three largest pharmaceutical companies.

The business covers more than 150 countries and regions around the world, and has 138,000 employees. Novartis China Headquarters was established in 1997. Novartis has a diversified portfolio of businesses that encompass innovative patented medicines, eye care, generic medicines and vaccines, consumer healthcare, and vaccines and diagnostics, all of which are world leaders.

On December 18, 2018, the World Brand Lab released the "2018 Top 500 World Brands", and Novartis ranked 308th. [3] In July 2019, the 2019 Fortune Global 500 was released: ranked 201st.

4] On May 13, 2020, Novartis ranked 68th on the 2020 Forbes Global 2000 list. It's so dry and boring.